Browse drugs

…0.91) and fibrosis or cirrhosis (HR 0.81; 95% CI 0.70 to 0.92). IL-17i (4579 matched pairs) and TNFi (15 007 matched pairs) treatment …

…der women. Overall, 94.4% reported ≥1 guideline-based potential PrEP indication. Based on the cumulative risk score, 3.6% reported 0…

… profibrotic or proinflammatory cytokines and then treated with nerandomilast. Investigations included cell proliferation, fibrosis-associate…

…nts could reduce the necessity for frequent hospital visits for Iloprost infusions.Further trials to determine which patients can safely…

…Introduction The prescription of Mycophenolate Mofetil (MMF) represents the primary treatment for interstitial lung di…

…ed so was discontinued.Other medications tried were colchicine, hydroxychloroquine, IV-Ig, and cyclosporine, tocilizumab and abatacept with subopt…

…rcinoma of the right lung, started treatment with cisplatin and pemetrexed. Two days after administration of chemotherapy, ischaemia of II…

…markers, pulmonary hypertension, or hospitalization.Conclusions LL37 elevation is associated with vascular complications and lung fu…

…ion of PrEP users.Material and Methods Retrospective study. All PrEP users followed at the Infectious Diseases Day Hospital of Perug…

…4) subgroups and in patients aged ≥90 years (n=160).Conclusions Tenecteplase and alteplase showed comparable efficacy and safety in patients…

…he substances most frequently reported were mephedrone (60.6%), GHB/GBL (41.9%), and cocaine (40.5%). Ketamine use was also substantial…

…d with weight gain and metabolic alterations. Regimens based on doravirine (DOR), a newer-generation non-nucleoside reverse transcriptase …